相关实验视频

Updated: Jun 25, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.7K

对单克隆抗体及其下一代衍生物的临床前评估的综合方法

Santanu Singh1, Kajal Kachhawaha1, Sumit K Singh1

  • 1Laboratory of Engineered Therapeutics, School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, India.

Biochemical pharmacology
|May 26, 2024
PubMed
概括

综合性的临床前评估对于生物治疗的安全性和有效性至关重要. 评估个别的生物治疗药物,包括抗体模拟剂和结合剂,可以最大限度地减少不良反应和产品退出.

关键词:
抗体碎片的抗体碎片抗体与药物的结合物.生物治疗学 生物治疗学两种类型的双种类型.有效性 有效性.免疫性 免疫性 免疫性安全的安全的安全的安全的安全.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.3K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K